| 000 | 01566 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513195819.0 | ||
| 264 | 0 | _c19991214 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a1043-0342 | ||
| 024 | 7 |
_a10.1089/10430349950016500 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavis, B M | |
| 245 | 0 | 0 |
_aCharacterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy. _h[electronic resource] |
| 260 |
_bHuman gene therapy _cNov 1999 |
||
| 300 |
_a2769-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarmustine _xpharmacology |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEnzyme Stability |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aO(6)-Methylguanine-DNA Methyltransferase _xgenetics |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aRoth, J C | |
| 700 | 1 | _aLiu, L | |
| 700 | 1 | _aXu-Welliver, M | |
| 700 | 1 | _aPegg, A E | |
| 700 | 1 | _aGerson, S L | |
| 773 | 0 |
_tHuman gene therapy _gvol. 10 _gno. 17 _gp. 2769-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/10430349950016500 _zAvailable from publisher's website |
| 999 |
_c10541098 _d10541098 |
||